Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Quin-C7 | 871100-12-8 | MFCD34182190 | 99.8% | 431.48 g/mol | C25H25N3O4 | 10 MG
SDP

Catalog No. 5000284645
Encompass_Preferred

Quin-C7 is an orally active antagonist of formyl peptide receptor 2 (FPR2/ALX) used as a research reagent to study inflammatory signaling pathways. It exhibits anti-inflammatory activity and has been reported to ameliorate dextran sulfate sodium (DSS)-induced colitis in mouse models.

  • Orally active FPR2/ALX antagonist for in vivo and in vitro studies.
  • Demonstrated anti-inflammatory effects and efficacy in DSS-induced colitis models.
  • Chemical formula C25H25N3O4, molecular weight 431.48 g/mol.
  • CAS number 871100-12-8.
  • High purity (~99.8%) suitable for research applications.
  • Available as a 10 MG solid; soluble in DMSO for stock solutions.
  • For research use only; not for human or clinical use.

Catalog No. 50-002-84645 Supplier Medchemexpress LLC Supplier No. HYW66877510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Quin-C7 is an orally active antagonist of formyl peptide receptor 2 (FPR2/ALX) used as a research reagent to study inflammatory signaling pathways. It exhibits anti-inflammatory activity and has been reported to ameliorate dextran sulfate sodium (DSS)-induced colitis in mouse models.

  • Orally active FPR2/ALX antagonist for in vivo and in vitro studies.
  • Demonstrated anti-inflammatory effects and efficacy in DSS-induced colitis models.
  • Chemical formula C25H25N3O4, molecular weight 431.48 g/mol.
  • CAS number 871100-12-8.
  • High purity (~99.8%) suitable for research applications.
  • Available as a 10 MG solid; soluble in DMSO for stock solutions.
  • For research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.